These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 14736517

  • 1. 18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast cancer.
    Zornoza G, Garcia-Velloso MJ, Sola J, Regueira FM, Pina L, Beorlegui C.
    Eur J Surg Oncol; 2004 Feb; 30(1):15-9. PubMed ID: 14736517
    [Abstract] [Full Text] [Related]

  • 2. Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer.
    Gil-Rendo A, Zornoza G, García-Velloso MJ, Regueira FM, Beorlegui C, Cervera M.
    Br J Surg; 2006 Jun; 93(6):707-12. PubMed ID: 16622900
    [Abstract] [Full Text] [Related]

  • 3. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
    Fujii T, Yajima R, Tatsuki H, Kuwano H.
    Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
    [Abstract] [Full Text] [Related]

  • 4. FDG-PET for axillary lymph node staging in primary breast cancer.
    Crippa F, Gerali A, Alessi A, Agresti R, Bombardieri E.
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
    [Abstract] [Full Text] [Related]

  • 5. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.
    Veronesi U, De Cicco C, Galimberti VE, Fernandez JR, Rotmensz N, Viale G, Spano G, Luini A, Intra M, Veronesi P, Berrettini A, Paganelli G.
    Ann Oncol; 2007 Mar; 18(3):473-8. PubMed ID: 17164229
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer.
    Ahn JH, Son EJ, Kim JA, Youk JH, Kim EK, Kwak JY, Ryu YH, Jeong J.
    Acta Radiol; 2010 Oct; 51(8):859-65. PubMed ID: 20670083
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer.
    Barranger E, Grahek D, Antoine M, Montravers F, Talbot JN, Uzan S.
    Ann Surg Oncol; 2003 Jul; 10(6):622-7. PubMed ID: 12839846
    [Abstract] [Full Text] [Related]

  • 9. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
    Crippa F, Agresti R, Seregni E, Greco M, Pascali C, Bogni A, Chiesa C, De Sanctis V, Delledonne V, Salvadori B, Leutner M, Bombardieri E.
    J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
    Machida Y, Kubota K, Katayama T, Toriihara A, Shibuya H.
    Eur J Surg Oncol; 2013 Jan; 39(1):26-30. PubMed ID: 23122913
    [Abstract] [Full Text] [Related]

  • 11. Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.
    Dalus K, Reitsamer R, Holzmannhofer J, Rendl G, Pirich C, Kronberger C, Rettenbacher L.
    Nuklearmedizin; 2011 Jan; 50(1):33-8. PubMed ID: 21336417
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.
    Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, Kondo N, Kondo T, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.
    BMC Cancer; 2008 Jun 09; 8():165. PubMed ID: 18541009
    [Abstract] [Full Text] [Related]

  • 14. FDG PET positive lymph nodes are highly predictive of metastasis in breast cancer.
    Kumar R, Zhuang H, Schnall M, Conant E, Damia S, Weinstein S, Chandra P, Czerniecki B, Alavi A.
    Nucl Med Commun; 2006 Mar 09; 27(3):231-6. PubMed ID: 16479242
    [Abstract] [Full Text] [Related]

  • 15. Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience.
    Kim J, Lee J, Chang E, Kim S, Suh K, Sul J, Song I, Kim Y, Lee C.
    World J Surg; 2009 May 09; 33(5):943-9. PubMed ID: 19259728
    [Abstract] [Full Text] [Related]

  • 16. Factors affecting the accuracy of 18F-FDG PET/CT in evaluating axillary metastases in invasive breast cancer.
    Kutluturk K, Simsek A, Comak A, Gonultas F, Unal B, Kekilli E.
    Niger J Clin Pract; 2019 Jan 09; 22(1):63-68. PubMed ID: 30666022
    [Abstract] [Full Text] [Related]

  • 17. Discordant results in 18F-FDG PET/CT and ultrasound-based assessment for axillary lymph node metastasis detection: A large retrospective analysis in 560 patients with breast cancer.
    Parisse-Di Martino S, Faure C, Mognetti T.
    Cancer Treat Res Commun; 2021 Jan 09; 27():100344. PubMed ID: 33636590
    [Abstract] [Full Text] [Related]

  • 18. Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging.
    Taira N, Ohsumi S, Takabatake D, Hara F, Takashima S, Aogi K, Takashima S, Inoue T, Sugata S, Nishimura R.
    Jpn J Clin Oncol; 2009 Jan 09; 39(1):16-21. PubMed ID: 18997183
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.